Aptagen, LLC
RNA
Lysozyme
Protein
31 nM (reported value)
Selection Buffer (20 mM Tris (pH 7.5) 100 mM NaCl,5 mM MgCl2)
N/A°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Lysozyme (ID# 162)
5'rGprGprGprAprAprUprGprGprAprUprCprCprAprCprAprUprCprUprAprCprGprAprAprUprUprCprAprUprCprAprGprGprGprCprUprAprAprAprGprAprGprGprCprAprGprAprGprUprUprAprCprUprUprAprGprUprUprCprAprCprUprGprCprAprGprAprCprUprUprGprAprCprGprAprAprGprCprUprUp3'
41
25443.39 g/mole
800700 L/(mole·cm)
45.57%
1.25
31.78
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Cox and Ellington. "Automated Selection of Anti-Protein Aptamers." Bioorganic & Medicinal Chemsitry, 9 (2001): 2525-2531/
Have your aptamer oligo synthesized ORDER NOW
We are always looking for ways to improve. Please tell us what you think.